Entera Bio ENTX
NASDAQ ENTX
$3.22 -0.02 (-0.62%)
At close: Nov 11, 2026 · 4:00 PM EST

Entera Bio (ENTX) Depreciation & Amortization (CF) (2017 - 2026)

Updated

Entera Bio's Depreciation & Amortization (CF) came in at $9,000 for Q2 2026, up 28.6% from $7,000 a year earlier and up 28.6% from the prior quarter.

Analysis

Entera Bio (ENTX) Depreciation & Amortization (CF) (2017 - 2026) Analysis & Trends

Over the trailing twelve months to Jun 30, 2026, Entera Bio reported Depreciation & Amortization (CF) of $31,000, down 16.2% year-over-year; for FY2025, it was $30,000, down 34.8% from FY2024.

  • Depreciation & Amortization (CF) has declined in each of the last three years, with a five-year compound annual growth rate of -13.8% (FY2020 to FY2025).
  • Going back by year, Depreciation & Amortization (CF) was $46,000 in FY2024 (-17.9%), $56,000 in FY2023 (-12.5%), $64,000 in FY2022 (+20.8%) and $53,000 in FY2021 (-15.9%).
  • The Q2 2026 figure represents the highest quarterly Depreciation & Amortization (CF) since Q4 2024.
  • Year-over-year, Depreciation & Amortization (CF) increased in 1 of the last eight quarters, with an average decline of 19.9%.
  • The fastest year-over-year change in Depreciation & Amortization (CF) over five years came in Q1 2022 (growth of 77.8%), and the weakest in Q1 2025 (a decline of 38.5%).
  • Business Quant data shows ENTX's Depreciation & Amortization (CF) at $7,000 (Q1 2026), $7,000 (Q4 2025) and $8,000 (Q3 2025) in the three quarters before Q2 2026.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Dep. & Amort. (Qtr)
1 Eli Lilly 1,348.13 Bn 1,321.74 Bn 20.46 Bn 545.00 Mn
2 Johnson & Johnson 675.90 Bn 595.76 Bn 17.30 Bn 2.12 Bn
3 AbbVie 519.45 Bn 487.50 Bn 13.12 Bn 192.00 Mn
4 Merck 364.95 Bn 327.95 Bn 13.19 Bn 726.00 Mn
5 Novartis Ag 311.58 Bn 285.16 Bn - -
6 Astrazeneca 289.34 Bn 262.94 Bn 13.26 Bn 1.61 Bn
7 Amgen 251.64 Bn 203.30 Bn 7.58 Bn 1.12 Bn
8 Gilead Sciences 212.05 Bn 187.07 Bn 6.73 Bn 132.00 Mn
9 Pfizer 167.35 Bn 115.00 Bn 12.56 Bn 1.58 Bn
10 Entera Bio 563.51 Mn 269.58 Mn - 9,000.00
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2026 9,000.00
Jun 30, 2026 9,000.00
Mar 31, 2026 7,000.00
Dec 31, 2025 7,000.00
Sep 30, 2025 8,000.00
Jun 30, 2025 7,000.00
Mar 31, 2025 8,000.00
Dec 31, 2024 11,000.00
Sep 30, 2024 11,000.00
Jun 30, 2024 11,000.00
Mar 31, 2024 13,000.00
Dec 31, 2023 13,000.00
Sep 30, 2023 14,000.00
Jun 30, 2023 15,000.00
Mar 31, 2023 14,000.00
Dec 31, 2022 16,000.00
Sep 30, 2022 16,000.00
Jun 30, 2022 16,000.00
Mar 31, 2022 16,000.00
Dec 31, 2021 14,000.00
API Access

Entera Bio Depreciation & Amortization (CF) API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=depreciation-and-amortization-cf&ticker=ENTX&period=max&api_key=YOUR_API_KEY